<i>Gfap</i>Mutation and Astrocyte Dysfunction Lead to a Neurodegenerative Profile with Impaired Synaptic Plasticity and Cognitive Deficits in a Rat Model of Alexander Disease

Alexander disease (AxD) is a rare neurological disorder caused by dominant gain-of-function mutations in the gene for glial acidic fibrillary protein (<i>GFAP</i>). Expression of mutant protein results in astrocyte dysfunction that ultimately leads to developmental delay, failure to thrive, and intellectual and motor impairment. The disease is typically fatal, and at present there are no preventative or effective treatments. To gain a better understanding of the link between astrocyte dysfunction and behavioral deficits in AxD we recently developed a rat model that recapitulates many of the clinical features of the disease, including failure to thrive, motor impairment, and white matter deficits. In the present study, we show that both male and female AxD model rats exhibit a neurodegenerative profile with a progressive neuroinflammatory response combined with reduced expression of synaptic and mitochondrial proteins. Consistent with these results AxD rats show reduced hippocampal long-term potentiation and are cognitively impaired, as demonstrated by poor performance in the Barnes maze and novel object recognition tests. The AxD rat provides a novel model in which to investigate the impact of astrocyte pathology on central nervous system function and provides an essential platform for further development of effective treatments for AxD and potentially other neurodegenerative diseases with astrocyte pathology.<b>Significance Statement</b> Alexander disease (AxD) is a fatal neurodegenerative disorder caused by gain-of-function <i>GFAP</i> mutations. We recently developed a <i>Gfap</i> <sup>+/R237H</sup> rat model which demonstrates hallmark astrocyte pathology, myelin deficits, and motor impairment. Here, we show that <i>Gfap</i> <sup>+/R237H</sup> rats also exhibit reduced synaptic plasticity and cognitive deficits as additional clinically relevant phenotypes, further demonstrating its utility as a model. Hippocampal transcriptomic analysis in young adult animals reveals a neurodegenerative signature with an innate immune response and loss of synaptic and metabolic gene expression, features that are typically associated with chronic diseases of aging. These results reveal mechanisms by which astrocyte dysfunction leads to learning and memory deficits in AxD and perhaps contributes to other diseases such as Alzheimer's and Parkinson's.

Authors

Institutions

Publication Details

Journal
eNeuro
Published
2025-03-01
DOI
https://doi.org/10.1523/eneuro.0504-24.2025
Citations
6
Primary Topic
RNA regulation and disease
Type
article
Field-Weighted Citation Impact
4.84

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GfapMutation and Astrocyte Dysfunction Lead to a Neurodegenerative Profile with Impaired Synaptic Plasticity and Cognitive Deficits in a Rat Model of Alexander Disease

Robert F. Berman, Tracy L. Hagemann, Angelica Bachman, Ni‐Hsuan Lin et al.
6 citations
eNeuro
RNA regulation and disease
4.84
article

GfapMutation and Astrocyte Dysfunction Lead to a Neurodegenerative Profile with Impaired Synaptic Plasticity and Cognitive Deficits in a Rat Model of Alexander Disease

Robert F. Berman, Tracy L. Hagemann, Angelica Bachman, Ni‐Hsuan Lin, Sierra Coyne, Alyssa Frelka, Albee Messing, Robert A. Pearce, Matthew Matson
article en
6 citations

Abstract

Alexander disease (AxD) is a rare neurological disorder caused by dominant gain-of-function mutations in the gene for glial acidic fibrillary protein (<i>GFAP</i>). Expression of mutant protein results in astrocyte dysfunction that ultimately leads to developmental delay, failure to thrive, and intellectual and motor impairment. The disease is typically fatal, and at present there are no preventative or effective treatments. To gain a better understanding of the link between astrocyte dysfunction and behavioral deficits in AxD we recently developed a rat model that recapitulates many of the clinical features of the disease, including failure to thrive, motor impairment, and white matter deficits. In the present study, we show that both male and female AxD model rats exhibit a neurodegenerative profile with a progressive neuroinflammatory response combined with reduced expression of synaptic and mitochondrial proteins. Consistent with these results AxD rats show reduced hippocampal long-term potentiation and are cognitively impaired, as demonstrated by poor performance in the Barnes maze and novel object recognition tests. The AxD rat provides a novel model in which to investigate the impact of astrocyte pathology on central nervous system function and provides an essential platform for further development of effective treatments for AxD and potentially other neurodegenerative diseases with astrocyte pathology.<b>Significance Statement</b> Alexander disease (AxD) is a fatal neurodegenerative disorder caused by gain-of-function <i>GFAP</i> mutations. We recently developed a <i>Gfap</i> <sup>+/R237H</sup> rat model which demonstrates hallmark astrocyte pathology, myelin deficits, and motor impairment. Here, we show that <i>Gfap</i> <sup>+/R237H</sup> rats also exhibit reduced synaptic plasticity and cognitive deficits as additional clinically relevant phenotypes, further demonstrating its utility as a model. Hippocampal transcriptomic analysis in young adult animals reveals a neurodegenerative signature with an innate immune response and loss of synaptic and metabolic gene expression, features that are typically associated with chronic diseases of aging. These results reveal mechanisms by which astrocyte dysfunction leads to learning and memory deficits in AxD and perhaps contributes to other diseases such as Alzheimer's and Parkinson's.

eNeuroVol. 12(3)
University of Wisconsin–Madison (US), National Tsing Hua University (TW), Institute of Molecular Medicine (IN), Neurological Surgery (US), University of California, Davis (US)
National Institute of Neurological Disorders and Stroke
Good health and well-being
Openalex Percentile: Top 5%
RNA regulation and disease
4.84
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.